Medical device and MedTech insights, news, tips and more

Employee at N.J. Medical Device Company Charged with Accepting Bribes

March 28, 2016

Accepting Bribes

Accepting Bribes

Authorities have charged an employee of a New Jersey medical device company with accepting bribes worth $75,000 in return for helping secure a contract worth millions of dollars for a metallurgical technology company.

The United States Attorney for New Jersey on Wednesday charged Daniel Lawrynowicz, 46, of Monroe, N.Y. with violating the Federal Travel Act in connection with the alleged bribe.

The U.S. Attorney’s office did not identify the medical device company for whom Lawrynowicz worked. But a LinkedIn page posted by a Daniel Lawrynowicz identifies him as an employee of Stryker, of Mahwah, which makes medical devices.

The page says Lawrynowicz got a Ph.D in materials engineering from the University of California in Irvine, says he is senior director of advanced technology at Stryker, and “leads a team of 41 engineers and scientists.”

The U.S. Patent and Trademark Office lists at least half a dozen patents filed by Daniel Lawrynowicz, of Monroe, along with others, between 2010 and 2013, while he worked for Howmedica Osteonics Corp., of Mahwah, which is now known as Stryker.

Jeanine Guilfoyle, a spokeswoman for Stryker, said the company would not comment on the case or Lawrynowicz’s employment at the company.

Lawrynowicz appeared before U.S. Magistrate Judge James B. Clark III in Newark Wednesday afternoon. If found guilty of the charge, he would face up to five years in prison and a $250,000 fine.

The complaint against Lawrynowicz says that in 2012 or 2013 the metallurgical technology company, which also is not identified, made a series of payments to him to secure the contract. The company has acknowledged making the payments, and a representative supplied investigators with documentation of “cash withdrawals consistent with such a cash bribe,” the complaint says.

Read More – Source: N.J. medical device company employee charged with accepting bribes – News –


More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.